Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial (Q36932702)

From Wikidata
Revision as of 01:58, 20 June 2022 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article published on 25 November 2015
edit
Language Label Description Also known as
English
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
scientific article published on 25 November 2015

    Statements

    Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial (English)
    Emre Altinmakas
    Zita Dubauskas Lim
    Pheroze Tamboli
    Kanishka Sircar
    David F McDermott
    Christopher G Wood

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit